Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shandong Yizhengda Pharmaceutical Technology is a Chinese pharmaceutical and biotechnology company specializing in the research, development, and manufacturing of traditional Chinese medicine extracts and medical products. Founded in 2015 and headquartered in Jining, Shandong Province, the company focuses on the isolation, purification, and quality control of natural plant extracts, particularly total saponins from Bacopa monnieri. Its research targets nervous system disorders such as depression, dementia, and Alzheimer's disease, as well as oncology indications. In addition to its botanical drug research, Shandong Yizhengda develops and manufactures medical devices and health products, including water-based lubricants and sanitary supplies. The company operates primarily in the pre-clinical stage, leveraging proprietary macroporous resin purification and high-performance liquid chromatography (HPLC) technologies to advance its product offerings.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shandong Yizhengda Pharmaceutical Technology.